← Eichor
Study identifier: NCT06694181 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safe and Explainable AI

Condition: Artifical Inteligence · Cardiology · Breast Cancer  ·  Sponsor: Abramson Cancer Center at Penn Medicine

PhaseN/A
Planned participants300000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical knowledge effectively, making AI recommendations explainable to clinicians, and establishing safety guarantees.

This description comes directly from the study's public registry record.

Talk to the study team

Haideliza Soto Calderon  ·  215-220-9425  ·  haideliza.soto-calderon@pennmedicine.upenn.edu

Nicholas Bishop  ·  nicholas.bishop@pennmedicine.upenn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06694181